<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: To evaluate the cognitive performance of a homogeneous population of <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> (AD), non-<z:e sem="disease" ids="C0860630" disease_type="Mental or Behavioral Dysfunction" abbrv="">demented</z:e> Type 2 <z:hpo ids='HP_0000819'>Diabetes Mellitus</z:hpo> (DIAB), <z:e sem="disease" ids="C0860630" disease_type="Mental or Behavioral Dysfunction" abbrv="">demented</z:e> with concomitant diseases (AD+DIAB) and healthy control subjects </plain></SENT>
<SENT sid="1" pm="."><plain>AD is a <z:hpo ids='HP_0000726'>progressive dementia</z:hpo> disorder characterized clinically by impairment of memory, cognition and behavior </plain></SENT>
<SENT sid="2" pm="."><plain>Recently, a major research interest in AD has been placed on early evaluation </plain></SENT>
<SENT sid="3" pm="."><plain><z:mp ids='MP_0002055'>Diabetes</z:mp> is one of the clinical conditions that represent the greatest risk of developing <z:mp ids='MP_0003674'>oxidative stress</z:mp> and <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="105" ids="17234">Glucose</z:chebi> overload, leading to the development of impaired-induced insulin secretion in DIAB and has been suggested to slow or deter AD pathogenesis </plain></SENT>
<SENT sid="5" pm="."><plain>METHODS: The degree of <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> was determined on the <z:hpo ids='HP_0002511'>Alzheimer Disease</z:hpo> Assessment Scale-Cognitive (ADAS-Cog) and the Folstein's Mini Mental State Examination (MMSE); the severity of <z:hpo ids='HP_0000726'>dementia</z:hpo> was quantified applying the Clinical <z:hpo ids='HP_0000726'>Dementia</z:hpo> Rating (CDR) test; the Hamilton test was employed to evaluate depressive conditions; the final population studied was 101 subjects </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: The <z:e sem="disease" ids="C0854193" disease_type="Mental or Behavioral Dysfunction" abbrv="">cognitive deterioration</z:e> is statistically significantly lower (p&lt;0.05) in AD+DIAB patients as compared with AD patients </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: In this longitudinal study the superimposed diabetic condition was associated with a lower rate of <z:hpo ids='HP_0001268'>cognitive decline</z:hpo>, while diabetic non-<z:e sem="disease" ids="C0860630" disease_type="Mental or Behavioral Dysfunction" abbrv="">demented</z:e> patients and controls present <z:mpath ids='MPATH_458'>normal</z:mpath> scores </plain></SENT>
</text></document>